Skip to main content

Advertisement

Table 2 Tumor Response, RECIST (N = 115)

From: Clinical outcomes and prognostic factors of cyberknife stereotactic body radiation therapy for unresectable hepatocellular carcinoma

Clinical feature N (%) Survival Rate p
1-yr (%) 2-yrs (%)
Complete Response 56 (48.7) 87.5 68.57  
Partial Response 46 (40) 39.13 12.5  
Stable 10 (8.7) 70 50  
Tumor progression 3 (2.61) 0 0 0.001